AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
20.58
+1.52 (7.97%)
Apr 17, 2025, 4:00 PM EDT - Market closed
AnaptysBio Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 36.38, with a low estimate of 20 and a high estimate of 51. The average target predicts an increase of 76.77% from the current stock price of 20.58.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2025.
Analyst Ratings
The average analyst rating for AnaptysBio stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 2 | 2 | 2 | 1 | 1 |
Buy | 5 | 5 | 5 | 6 | 5 | 5 |
Hold | 2 | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 11 | 12 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +104.08% | Mar 5, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $22 | Hold | Reiterates | $22 | +6.90% | Mar 4, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $40 → $51 | Buy | Maintains | $40 → $51 | +147.81% | Feb 13, 2025 |
Wedbush | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +94.36% | Feb 7, 2025 |
Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
Financial Forecast
Revenue This Year
49.50M
from 91.28M
Decreased by -45.77%
Revenue Next Year
68.19M
from 49.50M
Increased by 37.76%
EPS This Year
-5.50
from -5.12
EPS Next Year
-5.32
from -5.50
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 149.7M | 207.9M | 146.6M | ||
Avg | 49.5M | 68.2M | 73.9M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 64.0% | 320.0% | 115.0% | ||
Avg | -45.8% | 37.8% | 8.4% | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.81 | -1.47 | -2.75 | ||
Avg | -5.50 | -5.32 | -5.87 | ||
Low | -6.53 | -6.79 | -10.56 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.